United Kingdom

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
0.2 (0.10 - 0.40)	2014	Survey/reported	Price, 2016
0.22 (0.17 - 0.30)	2015	Modelled	WHO
0.7 (0.50 - 0.90)	2016	Modelled	Razavi-Shearer et al, 2018
0.01 (0.01 - 0.01)	2013	Modelled	Schweitzer et al, 2015
0.71 (0.61 - 0.80)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.78 (0.67 - 0.88)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.67 - 0.88)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.68 - 0.88)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.69 - 0.88)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.88)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.89)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.89)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.89)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
0.79 (0.68 - 0.89)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.68 - 0.89)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
0.78 (0.67 - 0.88)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.88)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.87)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.88)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.89)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.89)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.89)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.89)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.89)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.22 (0.16 - 0.31)	2015	Modelled	WHO
0.07 (0.05 - 0.09)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.12 (0.09 - 0.15)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.16)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.18)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
0.34 (0.25 - 0.45)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.40 - 0.71)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.41 - 0.72)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.42 - 0.73)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.57 (0.42 - 0.73)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.57 (0.42 - 0.73)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.57 (0.43 - 0.73)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.42 - 0.73)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.41 - 0.72)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.40 - 0.71)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
0.53 (0.39 - 0.70)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.69)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
0.52 (0.38 - 0.68)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.68)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.37 - 0.67)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
0.5 (0.37 - 0.66)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
0.5 (0.37 - 0.66)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
0.5 (0.37 - 0.66)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.67)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
0.52 (0.38 - 0.68)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
0.53 (0.39 - 0.69)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.39 - 0.70)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.40 - 0.71)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.40 - 0.71)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.40 - 0.71)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.40 - 0.72)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.40 - 0.72)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.41 (0.36 - 0.47)	2020	Modelled	WHO

Showing out of

Pregnant women

Download

Value (%)	Year	Type	Source
0.5 (0.40 - 0.50)	2016	Modelled	ECDC
0.3 (0.30 - 0.30)	2010	Survey/reported	Schnier C et al, 2014
1 (0.90 - 1.20)	2010	Survey/reported	Godbole G et al, 2013

Showing out of

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0.19	2017	Survey/reported	EMCDDA
0.43	2016	Survey/reported	EMCDDA
0.4	2015	Survey/reported	EMCDDA
0.58	2014	Survey/reported	EMCDDA
0.57	2013	Survey/reported	EMCDDA
0.94	2012	Survey/reported	EMCDDA
0.74	2011	Survey/reported	EMCDDA

Showing out of

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
0 (0 - 4.50)	2001	Survey/reported	Roy KM et ao, 2008
1 (0.40 - 2.30)	2013	Survey/reported	McMillan A, 2006
0.31	2017	Survey/reported	ECDC Monitoring Report

Showing out of

Prisoners

Download

Value (%)	Year	Type	Source
1.6 (0.80 - 2.90)	2016	Modelled	ECDC

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
441,000 (307,000 - 620,000)	2016	Modelled	Razavi-Shearer et al, 2018
474,826 (413,052 - 539,307)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
489,196 (425,936 - 554,767)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
488,755 (424,300 - 553,481)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
486,572 (421,563 - 550,643)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
485,717 (424,349 - 547,467)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
485,047 (423,970 - 545,423)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
482,463 (420,660 - 543,105)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
480,342 (419,252 - 540,552)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
478,273 (417,956 - 539,414)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
475,875 (414,931 - 537,425)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
472,827 (410,577 - 536,031)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
469,587 (408,055 - 532,460)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
466,571 (405,219 - 528,612)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
463,593 (402,340 - 524,957)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
460,472 (399,743 - 521,539)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
457,015 (396,557 - 517,519)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
452,453 (392,769 - 512,631)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
446,758 (387,884 - 506,911)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
440,858 (382,076 - 501,062)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
435,579 (377,451 - 496,188)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
431,774 (373,854 - 492,453)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
429,575 (371,668 - 489,630)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
428,129 (370,430 - 487,899)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
427,039 (370,076 - 486,673)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
425,984 (368,636 - 486,013)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
424,592 (367,564 - 484,929)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
422,920 (366,034 - 483,520)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
421,254 (364,646 - 482,787)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
419,605 (361,926 - 481,854)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
417,952 (360,341 - 480,198)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
416,339 (359,122 - 478,583)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
2.15 (1.87 - 2.47)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
1.05 (0.91 - 1.20)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
1.08 (0.93 - 1.24)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
1.02 (0.89 - 1.17)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
1.11 (0.96 - 1.27)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
1.15 (0.99 - 1.32)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1.21 (1.05 - 1.38)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
1.27 (1.10 - 1.45)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1.33 (1.15 - 1.52)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1.4 (1.21 - 1.61)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1.48 (1.27 - 1.70)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1.53 (1.31 - 1.76)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1.59 (1.36 - 1.83)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1.66 (1.44 - 1.92)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1.72 (1.50 - 1.99)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1.85 (1.61 - 2.13)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1.8 (1.56 - 2.07)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1.76 (1.52 - 2.02)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1.89 (1.65 - 2.17)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1.93 (1.68 - 2.21)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1.94 (1.69 - 2.21)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1.97 (1.71 - 2.23)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
2 (1.75 - 2.28)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1.98 (1.73 - 2.25)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
2.07 (1.80 - 2.36)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
2.05 (1.78 - 2.33)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
2.12 (1.85 - 2.41)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
2.16 (1.88 - 2.47)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
2.17 (1.89 - 2.47)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
2.15 (1.87 - 2.47)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
2.16 (1.88 - 2.46)	2018	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
1,346	2016	Modelled	WHO
605 (523 - 692)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
589 (511 - 673)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
622 (537 - 713)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
667 (577 - 765)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
644 (558 - 737)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
706 (612 - 805)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
744 (643 - 851)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
829 (714 - 951)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
876 (755 - 1,008)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
784 (676 - 895)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
909 (782 - 1,048)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1,000 (864 - 1,153)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
949 (815 - 1,095)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1,042 (904 - 1,200)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1,068 (925 - 1,228)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1,100 (952 - 1,268)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1,141 (989 - 1,312)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1,175 (1,022 - 1,347)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1,208 (1,051 - 1,383)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1,225 (1,065 - 1,395)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1,292 (1,128 - 1,471)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1,268 (1,107 - 1,440)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1,250 (1,089 - 1,420)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1,329 (1,159 - 1,513)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1,352 (1,180 - 1,540)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
1,395 (1,216 - 1,588)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
1,430 (1,241 - 1,631)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
1,445 (1,258 - 1,645)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1,446 (1,257 - 1,645)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1,447 (1,256 - 1,659)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
1,447 (1,256 - 1,659)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
4 (3 - 4)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
3 (3 - 4)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
4 (3 - 4)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
3 (3 - 4)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
3 (3 - 4)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
4 (3 - 4)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
4 (3 - 5)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
4 (3 - 5)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
4 (3 - 5)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
4 (4 - 5)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 5)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 6)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 6)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 6)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
6 (5 - 7)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
6 (5 - 7)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
7 (6 - 8)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
7 (6 - 8)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 9)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
8 (6 - 9)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 10)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
9 (7 - 10)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
10 (8 - 12)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
12 (10 - 14)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
93	2021	Survey/reported	WHO/UNICEF

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
57	2017	Survey/reported	EMCDDA, 2019

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

None

Source:

HepB birth dose policy

Yes (for risk groups)

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

HCV testing policy

Risk-based

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
0.3 (0.10 - 0.30)	2015	Modelled	Blach et al, 2017
0.4 (0.20 - 0.80)	2014	Modelled	Gower et al, 2014
1.14 (0.93 - 1.39)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
1.14 (0.93 - 1.39)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1.14 (0.93 - 1.39)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1.35 (1.10 - 1.64)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
1.6 (1.31 - 1.95)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
1.69 (1.38 - 2.06)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
1.76 (1.44 - 2.15)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1.82 (1.49 - 2.23)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1.86 (1.52 - 2.27)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1.87 (1.53 - 2.29)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1.86 (1.53 - 2.28)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1.85 (1.52 - 2.27)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1.84 (1.51 - 2.26)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1.83 (1.49 - 2.24)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1.81 (1.48 - 2.22)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1.72 (1.41 - 2.11)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1.52 (1.24 - 1.86)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1.29 (1.05 - 1.57)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1.09 (0.89 - 1.33)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.22)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.21)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.19)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.18)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.18)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.17)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.95 (0.78 - 1.17)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.16)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.16)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.16)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.16)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
1.07 (0.87 - 1.30)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
47.2	2012	Survey/reported	EMCDDA
43	2011	Survey/reported	EMCDDA

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
0.15 (0.08 - 0.18)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
1.2 (0.60 - 2.20)	2014	Survey/reported	Price, 2016
0.4 (0.40 - 0.70)	2011	Survey/reported	O'leary, 2016
0.5	2019	Modelled	Jin et al. 2017
0.6 (0.40 - 1.20)	2014	Modelled	Gower et al, 2014

Showing out of

Men who have sex with men (MSM) Living with HIV

Download

Value (%)	Year	Type	Source
5.2 (2.20 - 9.10)	2019	Modelled	Jin et al. 2017

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
49.1 (47.40 - 50.90)	2013	Survey/reported	EMCDDA

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
2.1 (1.40 - 3.20)	2008	Survey/reported	Price H et al, 2013
1.6 (1.20 - 2)	2011	Survey/reported	Donson H et al , 2012
0.7	2016	Survey/reported	ECDC
2.3	2017	Survey/reported	ECDC
3.8	2019	Modelled	Jin et al. 2017

Showing out of

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
189,000 (91,000 - 211,000)	2015	Modelled	Blach et al, 2017
182,400 (162,300 - 203,500)	2015	Survey/reported	Public Health England
143,000 (122,400 - 164,500)	2018	Survey/reported	Public Health England
514,476 (419,183 - 629,020)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
515,220 (420,267 - 631,299)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
516,978 (421,356 - 632,880)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
519,488 (423,352 - 634,689)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
522,690 (426,200 - 638,319)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
526,586 (428,686 - 642,924)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
531,290 (433,028 - 648,332)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
537,520 (438,167 - 656,412)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
545,064 (444,442 - 665,611)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
553,712 (452,065 - 676,508)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
563,591 (460,276 - 688,899)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
617,159 (504,386 - 754,051)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
731,880 (597,795 - 893,401)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
868,682 (710,706 - 1,061,410)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
987,485 (808,818 - 1,210,090)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1,046,830 (856,901 - 1,285,460)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1,061,710 (869,899 - 1,303,360)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1,076,730 (882,933 - 1,320,710)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1,091,130 (894,557 - 1,336,920)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1,104,450 (904,802 - 1,354,140)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1,116,470 (914,000 - 1,368,740)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1,118,520 (916,732 - 1,367,240)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1,104,690 (903,219 - 1,349,730)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1,076,860 (877,746 - 1,316,280)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1,037,450 (845,591 - 1,269,260)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
989,131 (807,425 - 1,209,960)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
838,599 (685,640 - 1,022,050)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
714,580 (583,656 - 870,090)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
718,088 (585,643 - 873,408)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
724,246 (590,130 - 880,782)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
716,743 (582,859 - 873,118)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
22,100 (12,000 - 27,700)	2019	Modelled	Dugan et al., 2021

HCV-related death rate

National

Download

Value (Deaths per 100,000)	Year	Type	Source
4.28 (3.80 - 4.76)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
1.87 (1.68 - 2.07)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
1.91 (1.72 - 2.12)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
1.83 (1.64 - 2.03)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
1.94 (1.74 - 2.15)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
2 (1.79 - 2.22)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
2.08 (1.86 - 2.31)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
2.17 (1.94 - 2.41)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
2.37 (2.12 - 2.64)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
2.27 (2.03 - 2.52)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
2.48 (2.23 - 2.77)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
2.56 (2.30 - 2.86)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
2.66 (2.38 - 2.97)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
2.79 (2.50 - 3.11)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
2.89 (2.60 - 3.23)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
2.98 (2.67 - 3.32)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
3.2 (2.86 - 3.56)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
3.08 (2.76 - 3.42)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
3.32 (2.97 - 3.69)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
3.44 (3.08 - 3.81)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
3.52 (3.14 - 3.89)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
3.65 (3.24 - 4.03)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
3.9 (3.48 - 4.32)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
4.03 (3.60 - 4.46)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
3.77 (3.36 - 4.17)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
4.13 (3.68 - 4.56)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
4.25 (3.78 - 4.69)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
4.33 (3.85 - 4.79)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
4.34 (3.87 - 4.81)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
4.28 (3.80 - 4.76)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
4.31 (3.82 - 4.79)	2018	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
5,125	2016	Modelled	WHO
2,875 (2,554 - 3,202)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
2,875 (2,554 - 3,202)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
2,881 (2,558 - 3,204)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
2,890 (2,572 - 3,197)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
2,862 (2,544 - 3,167)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
2,792 (2,484 - 3,086)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
2,698 (2,404 - 2,981)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
2,621 (2,337 - 2,898)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
2,520 (2,247 - 2,786)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
2,415 (2,150 - 2,670)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
2,317 (2,061 - 2,562)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
2,223 (1,983 - 2,456)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
2,152 (1,928 - 2,383)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
2,065 (1,847 - 2,291)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1,973 (1,764 - 2,192)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1,884 (1,687 - 2,095)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1,811 (1,624 - 2,017)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1,748 (1,568 - 1,952)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1,676 (1,502 - 1,868)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1,590 (1,423 - 1,777)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1,527 (1,368 - 1,703)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1,473 (1,321 - 1,643)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1,400 (1,252 - 1,561)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1,332 (1,191 - 1,481)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1,268 (1,135 - 1,410)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1,213 (1,084 - 1,344)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
1,160 (1,039 - 1,288)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1,126 (1,008 - 1,248)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
1,105 (992 - 1,223)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
1,078 (966 - 1,193)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
1,051 (943 - 1,164)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
11 (10 - 12)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
10 (9 - 12)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
11 (10 - 12)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
11 (10 - 12)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
11 (10 - 13)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
12 (10 - 13)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
12 (11 - 13)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
13 (12 - 15)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
14 (12 - 15)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
13 (11 - 14)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
15 (13 - 16)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
16 (14 - 17)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
16 (15 - 18)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
17 (15 - 19)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
19 (17 - 21)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
20 (18 - 22)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
22 (19 - 24)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
25 (22 - 27)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
23 (21 - 26)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
26 (23 - 29)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
28 (25 - 31)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
32 (28 - 36)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
31 (27 - 35)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
30 (26 - 33)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
34 (30 - 37)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
35 (30 - 38)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
35 (31 - 39)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
35 (31 - 40)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
34 (30 - 38)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
34 (29 - 38)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
40 (37 - 44)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
57	2017	Survey/reported	EMCDDA, 2019

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

None

Source:

HepB birth dose policy

Yes (for risk groups)

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

HCV testing policy

Risk-based

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

Overview

HBV elimination goal

Year of goal

2030

HCV elimination goal

Year of goal

2030

Prevalence (national)

Modelled

IHME, GBD 2019 (accessed 2022)

IHME, GBD 2019 (accessed 2020)

Survey/surveillance

Hepatitis related deaths (national)

Modelled

IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available

HBV chart

Modelled

IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available

HCV chart

Prevalence < 5

HBV

0.41 (%)

2020, latest modelled

(0.36 - 0.47(%))

WHO

Prevalence PWID

HCV

49.10 (%)

2013, survey/surveillance

(47.40 - 50.90(%))

EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Latest news

CGHE Community of Practice Newsletter: November 2022

30 Nov 2022

Newsletters

View all

Action plan

Hepatitis C Action Plan for Scotland Phase 1: September 2006 – August 2008

2006

NHS Scotland

View all

Elimination champion

Professor John Dillon (2021)

You really need to make the steps smaller and simpler. Each step of the hepatitis C care cascade you lose people. People are too frightened, they can’t afford the bus fare, they have other commitments or can’t afford to be away from somewhere for the time.… And as that starts to be successful, we started to lift our eyes and think about how we can make this a place where there is no longer hepatitis C. Where it was just something that was a historical footnote in medical textbooks. That's a world I wanted to see and that's what drove my team and I to think about the ways we could do that.